Toward Clinical Genomics in Everyday Medicine: Perspectives and Recommendations

Precision or personalized medicine through clinical genome and exome sequencing has been described by some as a revolution that could transform healthcare delivery, yet it is currently used in only a small fraction of patients, principally for the diagnosis of suspected Mendelian conditions and for targeting cancer treatments. Given the burden of illness in our society, it is of interest to ask how clinical genome and exome sequencing can be constructively integrated more broadly into the routine practice of medicine for the betterment of public health. In November 2014, 46 experts from academia, industry, policy and patient advocacy gathered in a conference sponsored by Illumina, Inc. to discuss this question, share viewpoints and propose recommendations. This perspective summarizes that work and identifies some of the obstacles and opportunities that must be considered in translating advances in genomics more widely into the practice of medicine.

Citing Articles

Prospective on Imaging Mass Spectrometry in Clinical Diagnostics.

Moore J, Patterson N, Norris J, Caprioli R Mol Cell Proteomics. 2023; 22(9):100576.

PMID: 37209813 PMC: 10545939. DOI: 10.1016/j.mcpro.2023.100576.

Landscape of genetic variants in sporadic meningiomas captured with clinical genomics.

Leclair N, Shen E, Wu Q, Wolansky L, Becker K, Li L Acta Neurochir (Wien). 2022; 164(9):2491-2503.

PMID: 35881312 DOI: 10.1007/s00701-022-05316-5.

Comparing genome sequencing technologies to improve rare disease diagnostics: a protocol for the evaluation of a pilot project, Genome-wide Sequencing Ontario.

Hayeems R, Marshall C, Gillespie M, Szuto A, Chisholm C, Stavropoulos D CMAJ Open. 2022; 10(2):E460-E465.

PMID: 35609929 PMC: 9259466. DOI: 10.9778/cmajo.20210272.

Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease.

Marshall C, Chowdhury S, Taft R, Lebo M, Buchan J, Harrison S NPJ Genom Med. 2020; 5:47.

PMID: 33110627 PMC: 7585436. DOI: 10.1038/s41525-020-00154-9.

Engaging community stakeholders in research on best practices for clinical genomic sequencing.

Griesemer I, Staley B, Lightfoot A, Bain L, Byrd D, Conway C Per Med. 2020; 17(6):435-444.

PMID: 33026293 PMC: 7938705. DOI: 10.2217/pme-2020-0074.

References

Tunis S, Pearson S . Coverage options for promising technologies: Medicare's 'coverage with evidence development'. Health Aff (Millwood). 2006; 25(5):1218-30. DOI: 10.1377/hlthaff.25.5.1218. View

Khoury M, Berg A, Coates R, Evans J, Teutsch S, Bradley L . The evidence dilemma in genomic medicine. Health Aff (Millwood). 2008; 27(6):1600-11. DOI: 10.1377/hlthaff.27.6.1600. View

Henrikson N, Bowen D, Burke W . Does genomic risk information motivate people to change their behavior?. Genome Med. 2009; 1(4):37. PMC: 2684658. DOI: 10.1186/gm37. View

Jiang Y, Wang M . Personalized medicine in oncology: tailoring the right drug to the right patient. Biomark Med. 2010; 4(4):523-33. DOI: 10.2217/bmm.10.66. View

Walt D, Kuhlik A, Epstein S, Demmer L, Knight M, Chelmow D . Lessons learned from the introduction of personalized genotyping into a medical school curriculum. Genet Med. 2010; 13(1):63-6. DOI: 10.1097/GIM.0b013e3181f872ac. View

Ormond K, Hudgins L, Ladd J, Magnus D, Greely H, Cho M . Medical and graduate students' attitudes toward personal genomics. Genet Med. 2011; 13(5):400-8. DOI: 10.1097/GIM.0b013e31820562f6. View

Haga S, Carrig M, ODaniel J, Orlando L, Killeya-Jones L, Ginsburg G . Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. J Gen Intern Med. 2011; 26(8):834-40. PMC: 3138989. DOI: 10.1007/s11606-011-1651-7. View

Powell K, Cogswell W, Christianson C, Dave G, Verma A, Eubanks S . Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing. J Genet Couns. 2011; 21(1):113-26. DOI: 10.1007/s10897-011-9390-9. View

Sharp R, Goldlust M, Eng C . Addressing gaps in physician education using personal genomic testing. Genet Med. 2011; 13(8):750-1. DOI: 10.1097/GIM.0b013e318228821f. View

10.

Bard J . When public health and genetic privacy collide: positive and normative theories explaining how ACA's expansion of corporate wellness programs conflicts with GINA's privacy rules. J Law Med Ethics. 2011; 39(3):469-87. DOI: 10.1111/j.1748-720X.2011.00615.x. View

11.

Vijayaraghavan A, Efrusy M, Goke B, Kirchner T, Santas C, Goldberg R . Cost-effectiveness of KRAS testing in metastatic colorectal cancer patients in the United States and Germany. Int J Cancer. 2011; 131(2):438-45. DOI: 10.1002/ijc.26400. View

12.

Bloss C, Madlensky L, Schork N, Topol E . Genomic information as a behavioral health intervention: can it work?. Per Med. 2011; 8(6):659-667. PMC: 3244209. DOI: 10.2217/pme.11.73. View

13.

Walko C, Mcleod H . Use of CYP2D6 genotyping in practice: tamoxifen dose adjustment. Pharmacogenomics. 2012; 13(6):691-7. DOI: 10.2217/pgs.12.27. View

14.

Dixon-Salazar T, Silhavy J, Udpa N, Schroth J, Bielas S, Schaffer A . Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med. 2012; 4(138):138ra78. PMC: 4442637. DOI: 10.1126/scitranslmed.3003544. View

15.

Tsurusaki Y, Kobayashi Y, Hisano M, Ito S, Doi H, Nakashima M . The diagnostic utility of exome sequencing in Joubert syndrome and related disorders. J Hum Genet. 2012; 58(2):113-5. DOI: 10.1038/jhg.2012.117. View

16.

Futema M, Plagnol V, Whittall R, Neil H, Humphries S . Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia. J Med Genet. 2012; 49(10):644-9. PMC: 3475071. DOI: 10.1136/jmedgenet-2012-101189. View

17.

Manolio T, Chisholm R, Ozenberger B, Roden D, Williams M, Wilson R . Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013; 15(4):258-67. PMC: 3835144. DOI: 10.1038/gim.2012.157. View

18.

Gymrek M, McGuire A, Golan D, Halperin E, Erlich Y . Identifying personal genomes by surname inference. Science. 2013; 339(6117):321-4. DOI: 10.1126/science.1229566. View

19.

Weng L, Zhang L, Peng Y, Huang R . Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy. Pharmacogenomics. 2013; 14(3):315-24. PMC: 3605891. DOI: 10.2217/pgs.12.213. View

20.

Salari K, Karczewski K, Hudgins L, Ormond K . Evidence that personal genome testing enhances student learning in a course on genomics and personalized medicine. PLoS One. 2013; 8(7):e68853. PMC: 3720862. DOI: 10.1371/journal.pone.0068853. View